CLOV vs TRDA
Clover Health Investments Corp (CLOV) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CLOV currently screens at market cap $1.55B. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CLOV and TRDA stock pages for the full models.
Not investment advice.